Determinants for the effectiveness of lifestyle intervention in the finnish diabetes prevention study

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 857-862

  Lindström, Jaana ^a,b   Peltonen, Markku ^a   Eriksson, Johan G ^a,b   Aunola, Slrkka ^a   Hämäläinen, Helena ^c   Ilanne Parikka, Pirjo ^d   Keinänen Kiukaanniemi, Sirkka ^e   Uusitupa, Matti ^f   Tuomilehto, Jaakko ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; WAIST CIRCUMFERENCE; BODY SIZE; DIABETES MELLITUS; DISEASE COURSE; FINLAND; GLUCOSE INTOLERANCE; HEART RATE; INCIDENCE; LIFESTYLE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE;

ADULT; BODY MASS INDEX; BODY SIZE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HEART RATE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS;

EID: 48649083316     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2162     Document Type: Article

References (19)

1. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and DiabetesStudy. Diabetes Care20:537-544, 1997
2. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEnglJMed344:1343-1350, 2001
3. The Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEngl J Med 346:393-403, 2002
4. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hä-mäläinen H, Härkönen P, Keinänen-Kiu-kaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: the follow-up results of the Finnish Diabetes Prevention Study. Lancet 368:1673-1679, 2006
5. Lindstrom J, Tuomilehto J: The Diabetes Risk Score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731, 2003
6. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uus-itupa M, Tuomilehto J: The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 6:3230 -3236, 2003
7. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech.Rep. Ser., no. 727)
8. Lakka TA, Salonen JT: Intra-person variability of various physical activity assessents in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 21:467-472, 1992
9. Ovaskainen M-L, Valsta L, Lauronen J: The compilation of food analysis values as a database for dietary studies-the Finnish experience. Food Chem 57:133-136, 1996
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Ho-meostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
11. Knowler WC, Narayan KM, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Schersten B, Pettitt DJ: Preventing non-insulin-dependent diabetes. Diabetes 44: 483-488, 1995
12. Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tog-noni G, Valentini M, Nicolucci A: Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 28:1187-1194, 2005
13. Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE: A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 39: 677-682, 2007
14. Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2:67-72, 2005
15. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
16. CrandallJ, Schade D, MaY, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R: The influence of age on the effects of lifestyle modification and met-formin in prevention of diabetes. JGeron- tolABiolSciMedSci61:1075-1081, 2006
17. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299-302, 2007
18. Saaristo T, Peltonen M, Keinänen-Kiu-kaanniemi S, Vanhala M, Saltevo J, Nis- kanen L, Oksa H, Korpi-Hyövälti E, Tuomilehto J: National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 66: 101-112, 2007
19. Schwarz P, Lindström J, Kissimova-Skar-bek K, Szybinski Z, Barengo N, Peltonen M, Tuomilehto J: The European perspective of type 2 diabetes prevention: Diabetes in Europe-Prevention using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 116:167-172, 2008